Results 121 to 130 of about 9,088,322 (356)

Social Bots for Online Public Health Interventions

, 2018
According to the Center for Disease Control and Prevention, in the United States hundreds of thousands initiate smoking each year, and millions live with smoking-related dis- eases. Many tobacco users discuss their habits and preferences on social media.
Allem, Jon-Patrick, Deb, Ashok, Ferrara, Emilio, Majmundar, Anuja, Matsui, Akira, Seo, Sungyong, Tandon, Rajat, Yan, Shen   +7 more
core   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Late antenatal care initiation: the case of public health centers in Ethiopia [PDF]

, 2018
Solomon Weldemariam, Ashenafi Damte, Kedir Endris, Melba C. Palcon, Kidisti Tesfay, Almaz Berhe, Tsige Araya, Hadgay Hagos, Haftom Gebrehiwot   +8 more
openalex   +1 more source

Public-Private Health Law: Multiple Directions in Public Health [PDF]

, 2007
No public law is more public than public health law. Its defining subject is the use of state power to control and prevent death and disease. Its primary institutions are a cluster of state actors, the governmental agencies that comprise the American ...
Hunter, Nan D.
core   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Careers in Public Health [PDF]

, 2009
Mandeville, K
core   +1 more source

PUBLICITY AND THE PUBLIC HEALTH [PDF]

American Journal of Public Health, 1914
openaire   +2 more sources

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

Molecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, Anne Sieben, Ella Roelant, Stig Hellemans, Elyne Backx, Laure Sorber, Koen De Winne, Senada Koljenović, Karen Zwaenepoel   +10 more
wiley   +1 more source

Social determinants and lifestyles: integrating environmental and public health perspectives

, 2016
Hilary Graham, Piran C. L. White
openalex   +1 more source

Public Health Versus Court-Sponsored Secrecy [PDF]

, 2006
Public health practice relies on access to information. Givelber and Robbins discuss the debate about court-sponsored secrecy: Whether or not courts should tolerate, edorse, or protect secrecy when the sequestered information might help protect the ...
Givelber, Daniel J., Robbins, Anthony
core   +1 more source